CorMedix (CRMD) Gross Margin Growth (3y) (2016 - 2025)
CorMedix (CRMD) Gross Margin Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,520.00 |
| Sep 30, 2025 | 1,081.00 |
| Jun 30, 2025 | -312.00 |
| Mar 31, 2025 | 1,591.00 |
| Dec 31, 2024 | 8,136.00 |
| Sep 30, 2024 | 6,008.00 |
| Jun 30, 2024 | 11,287.00 |
| Dec 31, 2022 | 18,479.00 |
| Sep 30, 2022 | 11,120.00 |
| Jun 30, 2022 | 5,835.00 |
| Mar 31, 2022 | 11,865.00 |
| Dec 31, 2021 | -175.00 |
| Sep 30, 2021 | 1,780.00 |
| Jun 30, 2021 | 26,969.00 |
| Mar 31, 2021 | 5,362.00 |
| Dec 31, 2020 | -17,115.00 |
| Sep 30, 2020 | 2,322.00 |
| Jun 30, 2020 | -10,341.00 |
| Mar 31, 2020 | 17,102.00 |
| Dec 31, 2019 | -11,591.00 |